Get the Stockscreener App
25.00
1.34%
-0.34
Pre-market:
25.00
Hemab Therapeutics Holdings Inc stock is traded at $25.00, with a volume of 461.15K.
It is down -1.34% in the last 24 hours and up +0.00% over the past month.
Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
See More
Previous Close:
$25.34
Open:
$23.81
24h Volume:
461.15K
Relative Volume:
29.28
Market Cap:
$1.17B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$23.81
$25.50
1-Week Range:
$23.81
$32.00
52-Week Range:
$23.81
$32.00
Hemab Therapeutics Holdings Inc Stock (COAG) Company Profile
Name
Hemab Therapeutics Holdings Inc
Sector
Industry
Phone
-
Address
-
Compare COAG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COAG
Hemab Therapeutics Holdings Inc
|
25.00 | 1.17B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Hemab Therapeutics Holdings Inc Stock (COAG) Latest News
Hemab, Seaport surge as clinical-stage biotechs make trading debuts - MSN
COAG Technical Analysis & Stock Price Forecast - Intellectia AI
Novo-backed biotech Hemab seeks to raise $212 million in US IPO - MSN
Hemab Therapeutics closes upsized IPO raising $346.7 million - Investing.com
COAG News Today | Why did Hemab Therapeutics stock go down today? - MarketBeat
Hemab Therapeutics closes $346.7 million IPO on Nasdaq - Investing.com UK
Hemab Therapeutics closes $346.7 million IPO on Nasdaq By Investing.com - Investing.com India
Hemab Therapeutics closes upsized IPO raising $346.7 million By Investing.com - Investing.com South Africa
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Hemab Therapeutics Holdings Inc. (COAG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Hemab's stock market debut brings in $346.7M after banks buy more shares - Stock Titan
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga
Number of employees of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Hemab Therapeutics Holdings, Inc (COAG) Stock Price Today & Analysis - Gotrade
Novo-backed biotech Hemab raises $301.5 million in upsized IPO - MSN
Free float of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Hemab Therapeutics (COAG) Stock Trends and Sentiment 2026 - MarketBeat
Hemab Therapeutics (COAG) 10K Form and Latest SEC Filings 2026 - MarketBeat
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Seaport, Hemab price upsized IPOs, eyeing $550M in proceeds - MSN
symbol__ Stock Quote Price and Forecast - CNN
COAG (Hemab Therapeutics Holdings) Cyclically Adjusted PS R - GuruFocus
COAG Price Today: Hemab Therapeutics Holdings, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Hemab Therapeutics IPO Debut Puts COAG And Pipeline Risks In Focus - Yahoo Finance
COAG Price History for Hemab Therapeutics Holdings Stock - Barchart.com
COAG Price Today: Hemab Therapeutics Holdings, Inc. Stock Price, Quote & Chart - MEXC Exchange
Latest Hemab Therapeutics Holdings, Inc. Common Stock Stock News & COAG Headlines - CoinCodex
Hemab Therapeutics Boosts IPO to 15 Million Shares From 11.8 Million - Moomoo
COAG Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
COAG Should I Buy - Intellectia AI
COAG PE Ratio & Valuation, Is COAG Overvalued - Intellectia AI
COAG News & Events - Intellectia AI
COAG Forecast — Price Prediction for 2026. Should I Buy COAG? - Intellectia AI
COAG Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Hemab, Seaport surge on trading debuts (SPTX:NASDAQ) - Seeking Alpha
Hemab Therapeutics Holdings' 16.8M-Share IPO Prices at $18 a Share - Moomoo
Hemab prices $301M in latest upsized biopharma IPO - BioWorld News
Seaport, Hemab price upsized IPOs eyeing $550M in proceeds - Seeking Alpha
Hemab Therapeutics sets terms for $200 million IPO - The Pharma Letter
COAG|Hemab Therapeutics Holdings Ord Shs (Proposed)|Price:34.280| - TradingKey
Hemab Therapeutics prices IPO at $18 per share By Investing.com - Investing.com Canada
Hemab Therapeutics prices IPO at $18 per share - Investing.com UK
EBITDA of Hemab Therapeutics Holdings Inc. – NASDAQ:COAG - TradingView
Working capital per share of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Diluted shares outstanding of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Total revenue of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Dilution adjustment of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Non-controlling/minority interest of Hemab Therapeutics Holdings Inc. – NASDAQ:COAG - TradingView
Cash from operating activities of HEMAB THERAPEUTICS HOLDINGS INC – NASDAQ:COAG - TradingView
Taxes of Hemab Therapeutics Holdings, Inc. – NASDAQ:COAG - TradingView
Discontinued operations of Hemab Therapeutics Holdings Inc. – NASDAQ:COAG - TradingView
Hemab Therapeutics Holdings Inc Stock (COAG) Financials Data
There is no financial data for Hemab Therapeutics Holdings Inc (COAG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.14%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):